April 24, 2019
TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients
The trial, for treatment of patients suffering from AcuteMyeloid Leukemia (AML), is being conducted at the Institute ofHematology and Blood Transfusion (ÚHKT) in Prague, Czech Republic.